Johnson & Johnson $40M Talc Verdict
Analysis based on 20 articles · First reported Dec 13, 2025 · Last updated Dec 15, 2025
The verdict against Johnson & Johnson could negatively impact its stock price and reputation, as it faces thousands of similar lawsuits. The ongoing legal battles and substantial payouts may lead to increased legal provisions and uncertainty for investors in the pharmaceutical and consumer goods industries.
A United States — California jury ordered Johnson & Johnson to pay $40 million to Monica Kent and Debbie Wasserman Schultz, who claimed the company's talc-based baby powder caused their ovarian cancer. Monica Kent was awarded $18 million, and Debbie Wasserman Schultz and her husband, Albert Schultz, were awarded $22 million. Johnson & Johnson plans to appeal the verdict, maintaining its products are safe and do not cause cancer. The company faces over 67,000 similar lawsuits and has previously attempted to resolve litigation through bankruptcy, which federal courts have rejected three times. Johnson & Johnson stopped selling talc-based baby powder in the United States in 2020 and globally in 2023, switching to a cornstarch product.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard